APA

Costello G. F., James R., Shaw J. S., Slater A. M. & Stutchbury N. C. (19910312). 2-(3,4-Dichlorophenyl)-N-methyl-N-[2-(1-pyrrolidinyl)-1-substituted- ethyl]-acetamides: the use of conformational analysis in the development of a novel series of potent opioid kappa agonists. : Journal of medicinal chemistry.

Chicago

Costello G F, James R, Shaw J S, Slater A M and Stutchbury N C. 19910312. 2-(3,4-Dichlorophenyl)-N-methyl-N-[2-(1-pyrrolidinyl)-1-substituted- ethyl]-acetamides: the use of conformational analysis in the development of a novel series of potent opioid kappa agonists. : Journal of medicinal chemistry.

Harvard

Costello G. F., James R., Shaw J. S., Slater A. M. and Stutchbury N. C. (19910312). 2-(3,4-Dichlorophenyl)-N-methyl-N-[2-(1-pyrrolidinyl)-1-substituted- ethyl]-acetamides: the use of conformational analysis in the development of a novel series of potent opioid kappa agonists. : Journal of medicinal chemistry.

MLA

Costello G F, James R, Shaw J S, Slater A M and Stutchbury N C. 2-(3,4-Dichlorophenyl)-N-methyl-N-[2-(1-pyrrolidinyl)-1-substituted- ethyl]-acetamides: the use of conformational analysis in the development of a novel series of potent opioid kappa agonists. : Journal of medicinal chemistry. 19910312.